文献速递心血管MR

晚期钆增强范围预测非缺血性心肌病患者的死亡、猝死和主要不良心血管事件:系统综述与荟萃分析

The extent of late gadolinium enhancement predicts mortality, sudden death and major adverse cardiovascular events in patients with nonischaemic cardiomyopathy: a systematic review and meta-analysis.
PubMed 文献 · Clin Radiol · 2023-01-13

该系统综述与荟萃分析纳入14项研究共4336例非缺血性扩张型心肌病患者,评估心脏磁共振晚期钆增强(LGE)范围的预后价值。结果显示LGE范围每增加1%与全因死亡、复合心律失常终点及MACE风险升高相关,校正基线特征后仍显著。LGE范围可能有助于优化NICM患者的临床事件或死亡预测模型。

要点

  • LGE范围每增加1%,全因死亡风险升高7%(校正后HR 1.07)。
  • LGE范围与复合心律失常终点和MACE风险独立相关。
  • LGE范围或可优化NICM患者的风险分层与预测模型。

核心结论

  • CMR的LGE范围可预测NICM患者的全因死亡、心律失常事件和MACE。
  • LGE范围可能有助于优化NICM患者临床事件或死亡的预测模型。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、EMBASE和Google Scholar数据库。
  • 从884篇文献中纳入14项研究,共4336例患者,平均年龄51.2岁,平均随访35.1个月。
  • 汇总 uniformly 定义的预测因素的未校正和校正风险比(HR)进行荟萃分析。

诊断标准与关键数值

  • LGE范围每增加1%,全因死亡未校正HR 1.07(95%CI 1.03-1.11,p=0.0003),校正后HR 1.07(95%CI 1.00-1.14,p=0.04)。
  • LGE范围每增加1%,复合心律失常终点未校正HR 1.09(95%CI 1.03-1.15,p=0.002),校正后HR 1.07(95%CI 1.02-1.012,p=0.004)。
  • LGE范围每增加1%,MACE未校正HR 1.06(95%CI 1.02-1.11,p=0.005),校正后HR 1.04(95%CI 1.01-1.08,p=0.005)。

临床应用与阅片要点

  • 在NICM患者CMR报告中量化LGE范围,可辅助识别全因死亡、心律失常事件和MACE高风险患者。
  • LGE范围可作为优化现有临床事件预测模型的候选影像标志物。

局限性

  • 纳入研究为观察性研究,存在混杂因素,校正后部分置信区间接近无效值。
  • 原文未报告各研究LGE量化方法、场强及扫描序列的异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To conduct a systematic review and meta-analysis with the objective of evaluating the prognostic value of extent of myocardial fibrosis by late gadolinium-enhanced cardiac magnetic resonance imaging (CMR) in non-ischaemic dilated cardiomyopathy (NICM).

MATERIAL AND METHODS: The databases PubMed, EMBASE, and Google Scholar were searched for studies that investigated the prognostic value of quantification of late gadolinium enhancement (LGE) in patients with NICM. Unadjusted and adjusted hazard ratios (HRs) of uniformly defined predictors were pooled for meta-analysis.

RESULTS: Fourteen studies were retrieved from 884 publications for this systematic review and meta-analysis. In total, 4,336 patients (mean age 51.2 years; mean follow-up 35.1 months) were included in the analysis. Meta-analysis showed the extent of LGE was associated with an increased risk of all-cause mortality (HR: 1.07/1% LGE; 95% confidence interval [CI]: 1.03-1.11; p=0.0003), composite arrhythmic endpoint (HR: 1.09/1% LGE; 95% CI: 1.03-1.15; p=0.002) and major adverse cardiovascular events (MACE; HR: 1.06/1% LGE; 95% CI: 1.02-1.11; p=0.005). After adjusting for baseline characteristics, the higher extent of LGE remained associated with the risk of all-cause mortality (HRadjusted: 1.07/1% LGE; 95% CI: 1.00-1.14; p=0.04), also strongly associated with the risk of composite arrhythmic endpoint (HRadjusted: 1.07; 95% CI: 1.02-1.012; p=0.004) and MACE (HRadjusted: 1.04; 95% CI: 1.01-1.08; p=0.005).

CONCLUSIONS: Extent of LGE in CMR predicts all-cause mortality, arrhythmic events, and MACE. Collectively, these findings emphasise that extent of LGE by CMR may have value for optimising current predictive models for clinical events or mortality in patients with NICM.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Golukhova, Bulaeva, Alexandrova, et al. The extent of late gadolinium enhancement predicts mortality, sudden death and major adverse cardiovascular events in patients with nonischaemic cardiomyopathy: a systematic review and meta-analysis. Clin Radiol. 2023. PMID: 36707397. doi:10.1016/j.crad.2022.12.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。